V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2) (Internal Region) Peptide
-
- Target See all AKT2 products
- AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
- Peptide Type
- Synthetic
- Protein Region
- Internal Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Characteristics
- SLC6A8 peptide is a 15 amino acid synthetic peptide near the internal region of SLC6A8.
-
-
- Application Notes
- AKT2 Peptide is used for blocking the activity of AKT2 antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- AKT2 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 ?L water, the concentration will be 0.5 mg/mL.
- Handling Advice
- When reconstituted minimize freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C.
-
- Target
- AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
- Synonyms
- AKT2 Peptide, pkbb Peptide, pkbbeta Peptide, pkbss Peptide, prkbb Peptide, rac-beta Peptide, v-akt2 Peptide, 2410016A19Rik Peptide, AW554154 Peptide, PKB Peptide, PKBbeta Peptide, HIHGHH Peptide, PKBB Peptide, PKBBETA Peptide, PRKBB Peptide, RAC-BETA Peptide, cb945 Peptide, akt2-a Peptide, AKT serine/threonine kinase 2 Peptide, v-akt murine thymoma viral oncogene homolog 2 Peptide, thymoma viral proto-oncogene 2 Peptide, v-akt murine thymoma viral oncogene homolog 2 L homeolog Peptide, AKT2 Peptide, akt2 Peptide, Akt2 Peptide, akt2.L Peptide
- Gene ID
- 208
- NCBI Accession
- NP_005682, NP_064693
- UniProt
- P31751
-